Lupus Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You are currently pregnant, or you were recently pregnant with a pregnancy outcome within the last year
- You received at least one dose of the medication anifrolumab at some point during your pregnancy, or in the 16 weeks before you became pregnant
Who may not be able to join:
- You are already enrolled in a separate related pregnancy registry study (known as D3461R00051)
- Your pregnancy was reported before this particular program began
- During your pregnancy, you were exposed to other medications that are known to cause birth defects, or to experimental/investigational medications (confirm with trial site)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Syd Philips, PPD Miami, US
Phone: 1-877-240-9479
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Major congenital malfunctions
Can't join this trial?
Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.